PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 17, 2026The Brazilian Journal of Infectious Diseases0 citationsOpen Access

Cost Reduction and Resource Optimization: Economic Evaluation of an Antimicrobial Program in an Infectious Diseases Hospital

View Full Paper
LDLucas Mendes Feitosa DiasKFKarine Kimberlly Rocha da FonsecaLPLílian Macambira Pinto

Key Points

  • This analysis evaluates the economic impact of the Antimicrobial Management Program on treatment costs in an infectious diseases hospital.
  • Descriptive and retrospective study design
  • Data collected from 2024 monitoring of the Antimicrobial Management Program
  • Performance indicators included planned versus actual expenditures and adherence to stewardship guidelines
  • Utilization of interdisciplinary clinical audits and reassessments to improve treatment
  • Projected antimicrobial expenditures estimated at R$590,626.48 for 2024
  • Actual spending reduced to R$298,503.35 through interventions, resulting in savings of R$292,123.13
  • Optimization rate of 50.54% achieved
  • Infection cure rates reached up to 27% in some months
  • Hospital mortality rates were below 26% among monitored patients

Abstract

The Antimicrobial Management Program (AMP) is an institutional strategy aimed at optimizing antimicrobial use in healthcare services, ensuring therapeutic efficacy, reducing adverse events associated with inappropriate use, preventing the selection of resistant microorganisms, and lowering unnecessary healthcare costs. In an infectious diseases hospital, patients often require intensive and prolonged antimicrobial use, making this setting particularly vulnerable to resistant bacteria and high expenditures on costly therapies. This study aimed to analyze the economic impact of the AMP on antimicrobial treatment costs in an infectious diseases hospital. This is a descriptive and retrospective study based on AMP monitoring data collected in 2024 in a tertiary hospital specializing in infectious diseases. Information was obtained from program performance indicators, including planned versus actual antimicrobial expenditure and adherence to clinical stewardship interventions. The study was approved under protocol number 7. 423. 682 and CAAE 85396524. 8. 0000. 5044. In 2024, projected antimicrobial expenditures were estimated at R590, 626. 48. Through AMP intervention strategies, actual spending totaled R298, 503. 35, resulting in direct savings of R292, 123. 13 and an optimization rate of 50. 54%. These results were achieved through interdisciplinary clinical audits, early treatment reassessments, and promotion of responsible use of broad-spectrum antimicrobials. The program also had a positive clinical impact, with infection cure rates of up to 27% in some months and hospital mortality rates below 26% among monitored patients. The AMP proved effective in reducing antimicrobial expenditures in an infectious diseases hospital without compromising clinical outcomes. The savings of over R290, 000 in a single year demonstrate the strategy’s economic potential, particularly in high-complexity settings. Strengthening such initiatives is essential for the sustainability of healthcare systems and the fight against antimicrobial resistance.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dias et al. (2026) studied this question.

synapsesocial.com/papers/69b8ef36deb47d591b8c5396https://doi.org/10.1016/j.bjid.2026.104711
Ask AI
Helpful
Bookmark
Share
View Full Paper